Quantum Biopharma

Quantum Biopharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Quantum Biopharma (QNTM.CN) as of Oct 27, 2026 is -15.32 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -15.88 M USD — a change of -3.57% (higher).

EBITDA

-15.32 MUSD

YoY

-3.57%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Quantum Biopharma is 2025 -15.32 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Quantum Biopharma was 2024 -15.88 M USD. It decreases by -3.57% higher compared to the previous year.

The Quantum Biopharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-24.41 M USD
Jan 1, 2019
-16.40 M USD
Jan 1, 2020
-17.70 M USD
Jan 1, 2021
-19.70 M USD
Jan 1, 2022
-27.43 M USD
Jan 1, 2023
-19.57 M USD
Jan 1, 2024
-15.88 M USD
Jan 1, 2025
-15.32 M USD
The Quantum Biopharma EBITDA history
YEAREBITDAYoY
-15.32 MUSD-3.57%
-15.88 MUSD-18.84%
-19.57 MUSD-28.65%
-27.43 MUSD+39.24%
-19.70 MUSD+11.32%
-17.70 MUSD+7.89%
-16.40 MUSD-32.81%
-24.41 MUSD+817.97%
-2.66 MUSD+1,907.02%
-132,500.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quantum Biopharma Stock analysis

What does Quantum Biopharma do? Quantum Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quantum Biopharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Quantum Biopharma is -15.32 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Quantum Biopharma changed from -15.88 M USD to -15.32 M USD, representing a -3.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Quantum Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Quantum Biopharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Quantum Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Quantum Biopharma